November 1, 2025: We added a way to get an exclusive Parkour Champions code worth 3 Super Champ skins and more for the latest playtest. What are some new Parkour Champions codes? If you're hoping to ...

A new drug combo is more effective in treating advanced prostate cancer The targeted drug niraparib added to hormone therapy slowed cancer growth and symptom progression Signs show the combo might ...

Ivonescimab plus chemotherapy improved PFS by 40% compared to Tevimbra in advanced squamous NSCLC, with a median PFS of 11.14 months versus 6.9 months. The study demonstrated consistent PFS benefits ...

A powerful new drug combo has yielded a major breakthrough for men battling an aggressive form of prostate cancer. Adding the drug enzalutamide to standard hormone therapy reduced the risk of ...

Combining enzalutamide with standard hormone therapy cut the risk of prostate cancer death by over 40% in a clinical trial The treatment targeted patients whose prostate cancer recurred aggressively ...

A new drug combo is offering hope for men with advanced prostate cancer. Adding the targeted cancer drug niraparib to hormone therapy reduced the risk of prostate tumor growth and slowed symptom ...

Already approved in the US for the treatment of adults with locally advanced or metastatic BTC, regulatory applications for Imfinzi plus chemotherapy are currently under review in Japan and several ...

Disclaimer: Glass's Information Services (GIS) and CarsGuide Autotrader Media Solutions Pty Ltd. (CarsGuide) provide this information based on data from a range of sources including third parties.

All products featured here are independently selected by our editors and writers. If you buy something through links on our site, Mashable may earn an affiliate commission. Despite the enthusiasm of ...

A new mix of two drugs—enzalutamide and leuprolide—has been shown to lower the risk of death by 40.3% for men with advanced, returning prostate cancer. This study with nearly eight years of follow-up, ...